4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-19-014933
Chief Scientific Officer sold 9,000 shares at $65.00 ($585,000)
- Chief Scientific Officer acquired 9,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Biller Scott Chief Scientific Officer | 2019-02-27 | Option exercise | +1,766 | $0.47 | $830 | 28,277 | D |
| Biller Scott Chief Scientific Officer | 2019-02-27 | Option exercise | +4,154 | $9.05 | $37,594 | 32,431 | D |
| Biller Scott Chief Scientific Officer | 2019-02-27 | Option exercise | +3,080 | $31.64 | $97,451 | 35,511 | D |
| Biller Scott Chief Scientific Officer | 2019-02-27 | Sale | −9,000 | $65.00 | $585,000 | 26,511 | D |
| Derivatives | |||||||
| Biller Scott Chief Scientific Officer | 2019-02-27 | Option exercise · Stock option (right to buy) | −1,766 | 0 | D | ||
| Biller Scott Chief Scientific Officer | 2019-02-27 | Option exercise · Stock option (right to buy) | −4,154 | 0 | D | ||
| Biller Scott Chief Scientific Officer | 2019-02-27 | Option exercise · Stock option (right to buy) | −3,080 | 11,782 | D | ||
| Open-market sales · 9,000 sh · avg $65.00 · $585,000 | |||||||
Loading xslF345X03/doc4.xml…